Search research articles
Contact Us
Filters
Showing results (171-180 of 177) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 177 results.
Nature Communications
|
February 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial
Xun Cao, Jia-Yu Zhou, Hao-Yang Huang, et al.
JAMA Oncology
|
March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial
Wang-Zhong Li, Xing Lv, Dan Hu, et al.
Journal of the National Cancer Institute
|
October 16, 2015
Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
Lin-Quan Tang, Chao-Feng Li, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Wei-Xiong Xia, Xing Lv, Hu Liang, et al.
The Lancet. Oncology
|
March 5, 2018
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
Lin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.
The New England Journal of Medicine
|
July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009
Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
JAMA
|
August 21, 2025
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial
, Cheng Xu, Xiao-Yu Liang, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 177) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 177 results.
Nature Communications
|
February 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial
Xun Cao, Jia-Yu Zhou, Hao-Yang Huang, et al.
JAMA Oncology
|
March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial
Wang-Zhong Li, Xing Lv, Dan Hu, et al.
Journal of the National Cancer Institute
|
October 16, 2015
Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
Lin-Quan Tang, Chao-Feng Li, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Wei-Xiong Xia, Xing Lv, Hu Liang, et al.
The Lancet. Oncology
|
March 5, 2018
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
Lin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.
The New England Journal of Medicine
|
July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009
Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
JAMA
|
August 21, 2025
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial
, Cheng Xu, Xiao-Yu Liang, et al.
Page
of 18